Responsiveness and minimum important change of the Pharmacotherapeutic Symptom Evaluation-20–Australian version: a tool for measuring changes in medicine-related symptoms over time
The PHASE-20-Australian version is responsive for most symptoms, with a clinically meaningful change of approximately 2.0 points on a 0-10 scale. The estimated MIC is applicable at the individual level, although caution is needed for symptoms with an MIC below the SDC.
Authors
- André Q Andrade (ORCID: https://orcid.org/0000-0001-6587-3169)
- Debra Rowett (ORCID: https://orcid.org/0000-0002-8977-0401)
- Renly Lim (ORCID: https://orcid.org/0000-0003-4135-2523)
- Elizabeth E. Roughead (ORCID: https://orcid.org/0000-0002-6811-8991)
- Mariann Hedström (ORCID: https://orcid.org/0000-0001-6296-0160)
- Abebe Basazn Mekuria (ORCID: https://orcid.org/0000-0003-2909-2001)
Institutions
- Uppsala University (SE)
- University of South Australia (AU)
- Institute for Medical Research (MY)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1007/s11096-025-02045-4
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of South Australia
- Medical Research Council
- National Health and Medical Research Council